Establishing secure connection…Loading editor…Preparing document…

FDA Disclaimer Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

FDA DISCLAIMER FORM

This FDA Disclaimer Form is entered into as of Date: , by and between Provider Name: , Provider Address: , and Recipient Name: , Recipient Address: . The parties agree as follows:

Recitals

WHEREAS, Provider develops, manufactures, markets or supplies the product(s) described as:

WHEREAS, Provider desires to distribute, market, or otherwise make available the product(s) to Recipient and Recipient desires to distribute, resell or otherwise use the product(s) subject to the terms of this Form; and

WHEREAS, the parties acknowledge that certain statements or representations related to the product(s) may be construed to concern the U.S. Food and Drug Administration, its approval, evaluation, or endorsement, and the parties wish to establish clear disclaimers and responsibilities with respect thereto.

NOW, THEREFORE

In consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the parties agree as follows.

1. Acknowledgment of FDA Status

Recipient acknowledges and agrees that any statements, claims or representations made by Provider or by Recipient regarding the product(s) have not been evaluated, approved, cleared, or endorsed by the Food and Drug Administration (FDA), unless an express written statement signed by both parties so states. Recipient shall not represent or imply FDA approval, clearance, or endorsement of the product(s) except as expressly authorized in writing by Provider.

2. Required Disclaimer Language

Recipient agrees to display the following disclaimer on all product packaging, advertising, promotional materials and websites where product(s) are offered for sale or distribution, in the form and placement required by Provider:

3. Representations and Warranties

Provider represents and warrants that to the best of its knowledge the labeling and promotional copy it supplies to Recipient does not knowingly contain false or misleading statements regarding the regulatory status of the product(s). Recipient represents and warrants that it will not alter required disclaimer language or make affirmative claims of FDA evaluation or approval unless Provider supplies express written authorization signed by an officer of Provider.

4. Indemnification

Recipient shall indemnify, defend and hold harmless Provider and its officers, directors, employees and agents from and against any and all claims, liabilities, losses, damages, penalties, fines, costs and expenses (including reasonable attorneys' fees) arising out of or relating to Recipient's failure to include or maintain the required disclaimer language, any misrepresentations to customers or regulators by Recipient, or Recipient's violation of applicable law in marketing or distributing the product(s).

5. Limitation of Liability

Except for liability arising from willful misconduct or gross negligence, neither party shall be liable to the other for incidental, consequential, special or punitive damages, and each party's aggregate liability under this Form shall not exceed the total amount paid by Recipient to Provider for the product(s) giving rise to the claim during the twelve (12) months preceding the event giving rise to liability.

6. Compliance with Laws

Each party shall comply with all applicable federal, state and local laws, rules and regulations in connection with its performance under this Form. Recipient shall maintain records demonstrating compliance with the requirements of this Form and shall produce such records to Provider upon reasonable request.

7. Audit and Corrective Action

Provider reserves the right to audit Recipient's marketing materials and product labeling upon reasonable notice. If Provider identifies noncompliant materials, Recipient shall promptly, and at its own expense, correct such materials and implement corrective measures satisfactory to Provider.

8. Notices

All notices required or permitted under this Form must be in writing and delivered to the addresses set forth below by certified mail, overnight courier, or hand delivery. Notice is effective upon receipt.

9. Amendments; Waiver

No amendment to this Form will be effective unless in writing and signed by authorized representatives of both parties. No waiver of any provision hereof shall be effective unless in writing and signed by the waiving party, and no single waiver will constitute a continuing waiver of the same provision.

10. Counterparts; Electronic Signatures

This Form may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument. Signatures transmitted by electronic means (including facsimile or PDF) shall be effective to bind the signing party.

11. Governing Law

This Form shall be governed by and construed in accordance with the laws of the State of , without regard to choice-of-law principles that would apply the laws of another jurisdiction.

12. Entire Agreement; Severability

This Form constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, negotiations and discussions, whether oral or written. If any provision of this Form is held to be invalid or unenforceable under any applicable statute or rule of law, that provision will be enforced to the maximum extent permissible and the remaining provisions will remain in full force and effect.

13. Certification

By signing below, each party certifies that it has the authority to enter into this Form, that the information provided in this Form is true and correct to the best of its knowledge, and that it understands and accepts the disclaimers, obligations and limitations set forth herein.

Acknowledgments

Recipient acknowledges that product claims have not been evaluated by the FDA.

Recipient will not represent or imply FDA endorsement or approval of the product(s).

Provider Name:

By:

Date:

Recipient Name:

By:

Date:

Enter text✕

What the FDA Disclaimer Form Is and When It’s Used

An FDA Disclaimer Form is a written statement used by manufacturers, marketers, and distributors to clarify that a product, claim, or communication has not been evaluated or approved by the U.S. Food and Drug Administration. It typically appears on promotional materials, websites, labeling, or consumer-facing documents for supplements, medical devices, cosmetics, or health-related items when claims might imply regulatory endorsement. The form reduces ambiguity about FDA status, supports compliance with advertising and labeling rules, and documents the party responsible for the statement.

Why an FDA Disclaimer Form Matters for Compliance

A clear FDA Disclaimer Form helps reduce regulatory risk by preventing misleading claims that could be treated as unauthorized representations of FDA evaluation or approval. It also documents the communication provenance and supports recordkeeping obligations under federal and state consumer protection rules.

Why an FDA Disclaimer Form Matters for Compliance

Who Typically Prepares and Signs an FDA Disclaimer Form

Organizations and roles that commonly prepare FDA disclaimers include product safety/legal teams, regulatory affairs, marketing, and compliance officers.

  • Regulatory Affairs — Drafts language to align with FDA guidance and internal review procedures; ensures statements do not imply clearance or approval.
  • Legal / Compliance — Reviews claims against FTC and FDA advertising rules and documents risk assessments and approvals.
  • Marketing / Product Teams — Ensures disclaimers are visible in consumer-facing materials and consistent across channels.

Final signatory authority often rests with a named officer, authorized agent, or in-house counsel depending on corporate policy and the document's distribution channel.

Key Elements to Include in a Professional FDA Disclaimer Form

A professional FDA Disclaimer Form is concise, unambiguous, and placed where consumers will reasonably see it. It should identify the product, clarify FDA status, name the issuer, and provide contact information for questions.

Product Identification

List the product name, model, or SKU to which the disclaimer applies so there is no doubt about the scope of the statement.

Clear FDA Status

State plainly that the product or claim has not been evaluated, cleared, or approved by the U.S. Food and Drug Administration when that is accurate.

Issuer Information

Include the legal entity name and address responsible for the communication so regulators and consumers know who issued the disclaimer.

Purpose and Limits

Explain the limited purpose of the statement (e.g., nutritional information, consumer education) and that it does not substitute for medical advice.

Visibility and Placement

Specify where the disclaimer will appear (labeling, website footer, marketing copy) and how it will be displayed to ensure readability.

Signature and Date

Provide space for an authorized signature and effective date to document when the disclaimer was issued and by whom.

Step-by-Step: Preparing and Approving an FDA Disclaimer Form

Follow a documented sequence to draft, review, approve, and publish the disclaimer to maintain an auditable trail.

  • 01
    Draft Language: Create concise text that accurately reflects FDA status without implying approval.
  • 02
    Internal Review: Have regulatory and legal teams review phrasing for conformity with advertising and labeling rules.
  • 03
    Signatory Approval: Obtain a signature from an authorized officer or designee with date and contact details.
  • 04
    Publish and Record: Place the disclaimer where consumers see it and save final signed copies in the official record system.

Configuring an Online Workflow for the FDA Disclaimer Form

Set up a repeatable eSignature workflow to route the form through drafting, legal review, signing, and archival stages.

Field Configuration
Drafting Single author with version control enabled
Reviewers Regulatory and legal assigned in sequence
Signer Designated officer, required signature and date
Archive Save signed PDF with audit trail

Typical eSubmission Flow for an FDA Disclaimer Form

Use a clear order for upload, field placement, signer assignment, authentication, and storage to preserve an audit trail.

  • Upload Document: Add the final disclaimer text to the form template.
  • Add Fields: Place signature, date, and contact fields where appropriate.
  • Assign Signer: Specify the authorized signer and routing order.
  • Store Signed Copy: Save PDF and capture audit trail metadata.

Technical Requirements for Secure eSigning and Storage

Choose a platform that supports secure transport, tamper-evident signed PDF output, and an accessible audit trail.

  • Encryption: TLS in transit; AES-256 at rest
  • Audit Trail: Timestamps, IP, and action logs
  • Integrations: Connectors for cloud storage and document management

These technical features help demonstrate intent, attribution, and record retention consistent with ESIGN (15 U.S.C. ch. 96) and applicable agency rules.

Security and Compliance Features to Verify

In-transit Encryption: TLS 1.2/1.3
At-rest Encryption: AES-256
Regulatory Certifications: SOC 2 Type II available
HIPAA Support: BAA available
21 CFR Part 11: Controls for electronic records
Access Controls: SSO and role-based access

Common Mistakes to Avoid When Preparing a Disclaimer

  • Using vague language that could be interpreted as implying FDA approval or review, which increases regulatory risk and consumer confusion.
  • Failing to associate the disclaimer with a specific product or communication channel, leaving scope unclear during enforcement or recall.
  • Omitting an effective date or signatory, which undermines auditability and complicates dispute resolution or compliance checks.
  • Placing the disclaimer in small font or behind a link where a reasonable consumer would not see it, risking misleading-advertising claims.

Penalties and Legal Risks for Misleading FDA Claims

Regulatory Enforcement: Warnings, injunctions, or product seizures
Civil Liability: Consumer class actions or FTC suits
Criminal Exposure: Intentional false claims can trigger criminal penalties
Reputational Harm: Loss of consumer trust and market access
Contract Risk: Breach claims if partners rely on false representations
Recordkeeping Failures: Penalties where retention obligations are unmet

Timing Considerations and Update Expectations

Maintain version control and review disclaimers whenever product claims, labeling, or marketing materials change; document each revision for audit purposes.

Initial Approval Date:

Record the effective date when the disclaimer is first published

Periodic Review:

Review language at least annually or on substantive product changes

Post-Change Update:

Update immediately after any claim or labeling alteration

Retention Start:

Retention begins on the signed effective date

Audit Readiness:

Keep accessible copies for the full retention period

Representative eSignature Pricing and Feature Comparison

Select an eSignature vendor that meets security and compliance needs; the table lists representative starting prices and feature flags for common providers.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial, no card Varies by plan and billing cycle Varies by plan and billing cycle Varies by plan and billing cycle Varies by plan and billing cycle
Bulk Send Yes Yes Yes Yes Varies by plan
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

FAQs and Troubleshooting for FDA Disclaimer Forms

Answers to common questions about wording, eSignature validity, retention, and when to involve legal counsel.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users